Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07314203 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Study acronym: SOP-XH-IRB
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Exploring the pathological complete response rate (pCR) of locally advanced gastric cancer treated with adebelimab combined or not combined with apatinib mesylate and SOX neoadjuvant therapy
Trial Details
NCT Number NCT07314203
Lead Sponsor Fujian Medical University
Conditions
(from sponsor)		 Gastric Cancer, Surgery
Related terms Stomach Neoplasms
Enrollment 118 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov